Skip to main content
. 2020 Aug 29;6(8):e04811. doi: 10.1016/j.heliyon.2020.e04811

Table 1.

Summary of TCGA-SKCM cohort used in this study.

Factor Value Percentage
Age (at diagnosis), in years
Mean 58.006
Median 58
Range
15–90

Gender
Male 280 62.36
Female
169
37.63
Ethnicity
Non-Hispanic/Non-Latino 426 94.88
Hispanic/Latino 10 2.23
Unknown
13
2.90
Race
White 426 94.88
Black/African American 1 0.22
Asian 12 2.67
Unknown
10
2.23
Known primary melanoma tumor
Yes 402 89.53
No
47
10.47
Location of primary melanoma
Head and Neck 35 7.80
Trunk 155 34.52
Extremity 194 43.21
Other 13 2.90
Unknown
52
11.58
Breslow thickness (mm)
Mean 5.49
Median 3
Unknown
105
23.39
Clark level
I–III 98 21.83
IV–V 211 46.99
Unknown
140
31.18
Ulceration status
Yes 159 35.41
No 141 31.40
Unknown
149
33.18
Mitotic rate
<1 19 4.23
≥ 1 151 33.63
Unknown
279
62.14
T stage
Tis 7 1.56
T0 23 5.12
T1 10 2.23
T1a 22 4.90
T1b 10 2.23
T2 30 6.68
T2a 31 6.90
T2b 15 3.34
T3 14 3.12
T3a 37 8.24
T3b 37 8.24
T4 15 3.34
T4a 23 5.12
T4b 104 23.16
TX 44 9.80
Unknown
27
6.01
N stage
N0 223 49.67
N1 16 3.56
N1a 18 4.01
N1b 38 8.46
N2 6 1.34
N2a 13 2.90
N2b 20 4.45
N2c 9 2.00
N3 53 11.80
NX 34 7.57
Unknown
19
4.23
M stage
M0 400 89.09
M1 5 1.11
M1a 4 0.89
M1b 5 1.11
M1c 9 2.00
Unknown
26
5.79
Pathological Stage
Stage 0 6 1.34
Stage I 30 6.68
Stage IA 18 4.01
Stage IB 29 6.46
Stage II 30 6.68
Stage IIA 17 3.79
Stage IIB 27 6.01
Stage IIC 58 12.92
Stage III 40 8.91
Stage III A 15 3.34
Stage III B 45 10.02
Stage III C 66 14.70
Stage IV 22 4.90
I/II NOS 10 2.23
Unknown
36
8.02
Anatomic site
Primary Tumor 91 20.27
Regional Lymph Node 218 48.55
Regional Cutaneous or Subcutaneous tissue 73 16.26
Distant Metastasis 64 14.25
Unknown
3
0.67
Overall Survival (months)
Mean 52.96
Median 29.5
Range
0–362.33

Vital Status
Alive 295 65.70
Dead 154 34.30